https://charts.traderzeitung.de/phases/US15678C1027
string(1364) "{"isin":"US15678C1027","name":"CeriBell Inc","stock_id":61067555,"generated_at":"2026-10-03 04:06:00","days":[{"date":"2026-09-30","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":24.405,"close_at":"2026-09-30 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-10-01","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":23.65,"close_at":"2026-10-01 21:59:00","complete":true,"perf_pct":-3.0936},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-10-02","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":23.7,"close_at":"2026-10-02 21:59:00","complete":true,"perf_pct":0.2114},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
CERIBELL Aktie News & Nachrichten
Trading-Room

CERIBELL Aktie News & Nachrichten

[WKN: A40N76 | Symbol: CBLL]
Realtimekurs
   
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

CERIBELL

Ceribell revolutioniert mit KI die EEG-Überwachung am Patientenbett

Ceribell (CBLL) traue ich nun den Anstieg auf das Allzeithoch zu. Das Medizintechnikunternehmen entwickelt...

Ceribell: KI-EEGs werden Standard in Akutkrankenhäusern – Marktpotenzial wächst auf 2,4?Mrd. USD!

Das Silicon Valley-Unternehmen Ceribell (CBLL) kann mit direkt am Krankenbett nutzbaren KI-gestützten...

  • ‹
  • 1
  • ›
CERIBELL Nachrichtenticker öffnen
MT Newswires 30.09.2026 13:33 Uhr

CeriBell erhält FDA-Zulassung für Plattform-Software-Update

07:32 AM EDT, 30.09.2026 (MT Newswires) -- CeriBell (CBLL) hat von der US-Arzneimittelbehörde FDA die Zulassung für ein Software-Update erhalten, das

MT Newswires 10.08.2026 14:43 Uhr

Ceribell erhält FDA-Zulassung für neue KI-Erweiterungen des Neurology Portal

08:42 AM EDT, 08/10/2026 (MT Newswires) -- CeriBell (CBLL) hat von der US-amerikanischen Lebensmittel- und Arzneimittelbehörde FDA die Zulassung für z

MT Newswires 05.08.2026 21:40 Uhr

Ceribell-Insider verkauft Aktien im Wert von 714.480 US-Dollar laut aktueller SEC-Meldung

03:39 PM EDT, 08/05/2026 (MT Newswires) -- Xingjuan Chao, Director, President und CEO, verkaufte am 03. August 2026 39.000 Aktien von Ceribell (CBLL)

MT Newswires 10.06.2026 18:58 Uhr

Ceribell Insider hat Aktien im Wert von $714.870 verkauft, laut einer aktuellen SEC-Einreichung

12:57 PM EDT, 06/10/2026 (MT Newswires) -- Xingjuan Chao, Director, President und CEO, hat am 08. Juni 2026 39.000 Aktien von Ceribell (CBLL) für $714